DrugEYE™, Data-driven drug discovery
DrugEYE™ provides Pharmaceutical companies, Research laboratories and Health authorities, precious foreknowledge about any emerging organism (virus, bacteria) immediately after it is detected and based on simple input. DrugEYE™ generates its output off-laboratory in a fully data driven way, saving months of wet lab research and funnelling the researcher’s efforts into the right direction.
- Functional characterization of the organism’s genes
- Prediction of the long term impacts on the human body
- Shortlist of candidate molecules to feed the drug discovery
Dynamic customer segmentation
Customer needs and expectations are changing rapidly, and traditional multi-criteria segmentation or clustering methods are no longer sufficient to act on the rapidly changing customer needs. The solutions allows to anticipate on customer needs based on a robust modelling of their behaviour and preferences, giving your company a leap ahead of the competition.
- AI inferred customer segmentation
- Automatic update of the segmentation identifying emerging customer behavioural patterns
- Ongoing recommendation engine for up-selling, cross-selling, Next Best Opportunities, Next Best Actions, best channel
Related news
MajestEYE winner of the "Best Artificial Intelligence solution in e-health" competition Jihed Hannachi - Co-Founder of MajestEYE receiving the award on behalf of MajestEYE In recent weeks, the spread of…
''Data! Data! Data! I cannot make bricks without clay"-Sherlock Holmes. Everyone knows that data is important to a start-up, but it's more complicated than that. Data is the foundation on…
MajestEYE is selected by JICA , the Japanese International Cooperation Agency, among the top 10 most innovative start-ups in Africa in the framework of the international innovation competition NINJA (Next…
What is the Africa By Incubme program? The Africa By Incubme (ABI) program was launched in 2018. It's an acceleration program for African start-ups in technological fields that seek to…
